MedPath

Treatment of Anxiety and Depression in Distressed Carers for Persons with Dementia-related Conditions

Not Applicable
Recruiting
Conditions
Depression
Anxiety
Mental Health - Depression
Mental Health - Anxiety
Registration Number
ACTRN12611000575932
Lead Sponsor
Macquarie University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
30
Inclusion Criteria

1) reporting at least moderate (sub-clinical or clinical) levels of anxiety and/or depressive symptoms; 2) CG for a person diagnosed with a dementia-related condition; 3) care recipient has a minimum of at least 12-month prognosis; 4) aged 18 to 80 years; 5) able to speak, read and write basic English; and 6) medically fit to respond to the assessment and intervention procedures.

Exclusion Criteria

(1) Presence of severe cognitive and language deficits for CGs (defined as score < 1.96 SD below mean) that will be assessed via a brief screening neuropsychological assessment battery (see measures); (2) current or prior history of significant alcohol/ drug abuse or psychosis; (3) current suicidal ideation; and (4) currently undergoing psychiatric treatment for mental illness.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Depression: Beck Depression Inventory (2nd Ed) [BDI-II], sample mean scores to reduce to non-clinical levels (< 14)[Baseline, end of therapy (10 weeks following commencement of intervention), 1-month and 3 -months follow up (i.e., 14 and 26 weeks following commencement of intervention).];Anxiety: State Trait Anxiety Scale (STAI), sample means scores to reduce to non-clinical levels [T scores < 60][Baseline, end of therapy (10 weeks following commencement of intervention), 1-month and 3 -months follow up (i.e., 14 and 26 weeks following commencement of intervention).];Acceptance: Acceptance and Action Questionnaire, sample mean scores will improve on acceptance subscale and reduce on experiential subscale.[Baseline, end of therapy (10 weeks following commencement of intervention), 1-month and 3 -months follow up (i.e., 14 and 26 weeks following commencement of intervention).]
Secondary Outcome Measures
NameTimeMethod
Coping strategies: BCOPE, sample means scores expected to improve on adapative coping and reduce on maladaptive coping.[Baseline, end of therapy (10 weeks following commencement of intervention), 1-month and 3 -months follow up (i.e., 14 and 26 weeks following commencement of intervention).];Quality of Life [QOL], SF-36: sample mean scores expected to increase reflecting improvment in QOL[Baseline, end of therapy (10 weeks following commencement of intervention), 1-month and 3 -months follow up (i.e., 14 and 26 weeks following commencement of intervention).];Caregiver Functionality: Positive Aspects of Caregiving Scale, sample means scores expected to improve.[Baseline, end of therapy (10 weeks following commencement of intervention), 1-month and 3 -months follow up (i.e., 14 and 26 weeks following commencement of intervention).]
© Copyright 2025. All Rights Reserved by MedPath